JUNE PHARMA LIMITED
Significant control: Philippe Masquida (75–100%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
What does June Pharma Limited sell?
Registered activity: Management consultancy activities other than financial management (SIC 70229). We’re building product and service lists for UK companies. Get this one when it’s ready.
Summary
JUNE PHARMA LIMITED is an active private limited company (company number 10197232) incorporated on 24 May 2016, registered in London. Its registered activity is management consultancy activities other than financial management (SIC 70229). Latest micro accounts cover the period ending 31 May 2026, showing net assets of £313k, with 2 employees on average. As micro-entity accounts, no profit and loss account is filed, so turnover and profit are not public. Net assets fell 18% on the prior period (£380k). Across the last 3 periods on record the net-asset trend is falling.
By net assets it sits in the top quarter of 31,398 comparable companies in London (median £2,815, upper quartile £34k).
Ownership and control
- Mr Philippe Masquida
- owns 75–100% of shares
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
Key dates
- Incorporated
- 24 May 201610 yrs ago
- Next accounts due
- 29 February 2028in 495 days
- Confirmation statement due
- 7 June 2027in 228 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
Activity
- SIC 70229
- Management consultancy activities other than financial management
- Accounts type
- Micro Entity
- Size band
- MicroCompanies Act thresholds
Financials
| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 May 2026 | £313k | — | — | £94k | — | — | 2 |
| 31 May 2025 | £380k | — | — | £99k | — | — | 1 |
| 31 May 2024 | £532k | — | — | £142k | — | — | 1 |
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing; micro-entity accounts contain no profit and loss account.
Filing and accounts signals
- Net assets above zeroNet assets £312,722 at 31 May 2026
- Current assets at least 1.5× creditors within one yearCurrent ratio 4.3
- Three or more accounting periods on record3 periods on record
- Incorporated five or more years agoIncorporated 24 May 2016
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
Timeline
- Next accounts duein 495 days
- Confirmation statement duein 228 days
- Accounts period endNet assets £313k · micro accounts
- Accounts period endNet assets £380k · micro accounts
- Accounts period endNet assets £532k · micro accounts
- Incorporated
Similar companies in London
- OYSTER ONE SERVICES LIMITEDLondon · inc. May 2016
- RESILIENT PANDA AND ASSOCIATES LIMITEDLondon · inc. May 2016
- DELTATRE GROUP LIMITEDLondon · inc. May 2016
- CHARISPLAN CONSULTING LTDLondon · inc. May 2016
- NINEGOLD CAPITAL (UK) LTDLondon · inc. May 2016
- QMARKETS U.K. LIMITEDLondon · inc. May 2016
All companies incorporated on 24 May 2016 · in May 2016.
Reminders for JUNE PHARMA LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.